The proportion of patients achieving a complete response was similar in both groups, along with similar improvements in serum albumin, complement, kidney function, systemic lupus erythematosus disease activity index and the British Isles Lupus Assessment Group score. This evidence concerns the gene ALB and systemic lupus erythematosus.